Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 5, p. 352, doi. 10.1007/s12272-022-01388-0
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2022 AND VI 45 AND IP 5
Results: 5
1
2
Function and therapeutic development of exosomes for cancer therapy.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 5, p. 295, doi. 10.1007/s12272-022-01387-1
- By:
- Publication type:
- Article
3
Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 5, p. 309, doi. 10.1007/s12272-022-01385-3
- By:
- Publication type:
- Article
4
Adapalene induces adipose browning through the RARβ-p38 MAPK-ATF2 pathway.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 5, p. 340, doi. 10.1007/s12272-022-01384-4
- By:
- Publication type:
- Article
5
Clerodane furanoditerpenoids from the stems of Tinospora sinensis.
- Published in:
- Archives of Pharmacal Research, 2022, v. 45, n. 5, p. 328, doi. 10.1007/s12272-022-01383-5
- By:
- Publication type:
- Article